Friday Nov 22, 2024
Friday Nov 22, 2024

Hemophilia

$2.9 million gene therapy for severe hemophilia

Jul 1, 2023
U.S. officials on Thursday approved drugmaker BioMarin’s gene therapy for the most common form of hemophilia.

Hemophilia therapy gets FDA approval

Nov 23, 2022
US health regulators on Tuesday approved the first gene therapy for hemophilia.

People with hemophilia to be counted in upcoming census

Sep 25, 2021
The government is going to count people with hemophilia in the national census-2078 BS.
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

Kathmandu, Nepal,


Newsroom
##

E-mail
nepalnewseditor@gmail.com

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal